Home · Safety · GLP-1 and Addiction: What the Research Shows

GLP-1 and Addiction: What the Research Shows

Emerging data on GLP-1 effects on alcohol use disorder, nicotine cravings, and gambling — research summary.

Released: Last reviewed:

Emerging data on GLP-1 effects on alcohol use disorder, nicotine cravings, and gambling — research summary.

Overview

Safety considerations for GLP-1 receptor agonists fall into a few categories: predictable GI effects that resolve with titration, less common but more serious effects that warrant clinical attention, and very rare effects that have driven boxed warnings or formal contraindications.

Who is at higher risk

Patient-specific risk factors — including age, comorbidities, concurrent medications, and family history — change the safety calculus. The factors that matter for this specific concern are detailed below.

When to involve your clinician

For most safety concerns on GLP-1 therapy, an asynchronous message to your prescribing clinician within 24–48 hours is appropriate. For severe symptoms — severe pain, persistent vomiting, signs of allergic reaction, or symptoms suggesting pancreatitis — seek emergency care.

Our editor's pick for a clinician-supervised program

NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.

Editor's pick for this category

Read the NexLife review →

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 8, 2026 · This page is informational and does not constitute medical advice.

Related guides